None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Adults aged 18 years or older. 2.Individuals diagnosed with latent tuberculosis infection (LTBI) through an Interferon-Gamma Release Assay (IGRA) test. 3.Individuals who have elected to undergo a 4-month rifampin monotherapy for LTBI treatment. 4.Individuals who understand the purpose of this study and voluntarily consent to participate. 5.Users of smartphones with an Android operating system.
Exclusion criteria
Exclusion criteria: This study applies a digital-based intervention and, due to technical requirements of the intervention platform, only participants using Android-based smartphones will be eligible. Individuals using iOS-based smartphones will be excluded due to technical limitations. In addition, individuals with high-risk conditions for tuberculosis progression (e.g., immunocompromised status, malignancy, chronic renal failure, or other severe underlying diseases) will be excluded, as their treatment course and psychological responses may differ from those of the general latent tuberculosis infection (LTBI) population.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| adherence to the scheduled medication time: | — |
Secondary
| Measure | Time frame |
|---|---|
| Healthcare Provider Support;Self-efficacy | — |
Countries
Korea, Republic of
Contacts
Seongnam Citizens Medical Center